KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) Tax Rate (2016 - 2025)

Historic Tax Rate for Halozyme Therapeutics (HALO) over the last 10 years, with Q4 2025 value amounting to 40.4%.

  • Halozyme Therapeutics' Tax Rate fell 635200.0% to 40.4% in Q4 2025 from the same period last year, while for Dec 2025 it was 32.13%, marking a year-over-year increase of 118400.0%. This contributed to the annual value of 32.13% for FY2025, which is 118400.0% up from last year.
  • Halozyme Therapeutics' Tax Rate amounted to 40.4% in Q4 2025, which was down 635200.0% from 19.97% recorded in Q3 2025.
  • Halozyme Therapeutics' 5-year Tax Rate high stood at 24.41% for Q2 2022, and its period low was 192.27% during Q3 2021.
  • Moreover, its 5-year median value for Tax Rate was 18.85% (2022), whereas its average is 2.11%.
  • As far as peak fluctuations go, Halozyme Therapeutics' Tax Rate tumbled by -1924400bps in 2021, and later soared by 2086500bps in 2022.
  • Halozyme Therapeutics' Tax Rate (Quarter) stood at 21.82% in 2021, then skyrocketed by 185bps to 18.49% in 2022, then dropped by -16bps to 15.6% in 2023, then skyrocketed by 48bps to 23.12% in 2024, then tumbled by -275bps to 40.4% in 2025.
  • Its last three reported values are 40.4% in Q4 2025, 19.97% for Q3 2025, and 19.42% during Q2 2025.